IVBXF
Innovent Biologics Inc/ADR
$11.06
+0.00 (+0.00%)
At close · Jul 3
Market Cap
$19.18B
Shares
1,734,623,465
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.06
Open$9.50
Day$9.50–9.79
52W$9.10–15.12
Avg vol 30d1K
Short int1.1M · 0.1% float · 43.0d
Short vol40%
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+1% above
+
Price vs 50-day avg
+7% above
◦
RSI (14)
61 · neutral
+
MACD trend
positive
◦
52-week position
33% · mid-range
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $10 › 200d $11 — 200d above 50d
◦
Institutional flow
No 13F holder data
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.06% of float · ▲ +8549.4% MoM · 43.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
No 13F holder history
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+1% above
Bullish
Price vs 50-day avg
+7% above
Bullish
RSI (14)
61 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
33% · mid-range
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $10 › 200d $11 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.06% of float · ▲ +8549.4% MoM · 43.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $9
Now $11 · 33%
52-wk high $15
vs 200-day avg +1%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IVBXF
this stock
Innovent Biologics Inc/ADR
|
$19.18B | +13.4% | — | — | 0.1% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IVBXF | +10.8% | +9.6% | -0.8% | +0.3% | +13.4% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +9.4% | +10.8% | -8.8% | +0.6% | +4.2% |